Ajanta Pharma Ltd - Clarification on news item

Ajanta Pharma Ltd - Clarification on news item
With reference to the news item appearing in a leading financial daily titled "Dabur in Talks with Ajanta to Acquire 30 - Plus Brand", Ajanta Pharma Ltd has clarified to BSE that" "the Company has made it clear to the journalist that it doesnot comment on the market speculation and the same has been mentioned by the newspaper article also. We once again reiterate that the news article is based on speculation and the Company has not issued any press release on the same. The Company's policy is to inform the stock exchange whenever it enters into any formal agreement on such sensitive subjects."
Listen to the latest songs, only on JioSaavn.com